What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Dopamine
- Gene
His primary scientific interests are in Internal medicine, Endocrinology, Dopamine, Neuroscience and Receptor.
His study in Catecholamine, Hypothalamus, Tyrosine hydroxylase, Apomorphine and Medulla oblongata falls under the purview of Internal medicine.
His Endocrinology research incorporates elements of Agonist, Neuropeptide Y receptor and Spinal cord.
He has included themes like Monoamine neurotransmitter, Stimulation and Pharmacology in his Dopamine study.
Kjell Fuxe combines subjects such as Neurotransmission and Anatomy with his study of Neuroscience.
His Dopamine receptor D2 research includes themes of Adenosine, Biophysics, Adenosine A2A receptor, Cell biology and Dopamine receptor.
His most cited work include:
- EVIDENCE FOR THE EXISTENCE OF MONOAMINE-CONTAINING NEURONS IN THE CENTRAL NERVOUS SYSTEM. I. DEMONSTRATION OF MONOAMINES IN THE CELL BODIES OF BRAIN STEM NEURONS. (4732 citations)
- EVIDENCE FOR THE EXISTENCE OF MONOAMINE NEURONS IN THE CENTRAL NERVOUS SYSTEM. 3. THE MONOAMINE NERVE TERMINAL. (1455 citations)
- Acetylcholine receptors containing the β2 subunit are involved in the reinforcing properties of nicotine (1160 citations)
What are the main themes of his work throughout his whole career to date?
Kjell Fuxe mainly focuses on Internal medicine, Endocrinology, Dopamine, Neuroscience and Receptor.
His Endocrinology research incorporates themes from Agonist and Neuropeptide Y receptor.
His research on Dopamine often connects related areas such as Pharmacology.
His research in Neuroscience intersects with topics in Glutamate receptor, Monoamine neurotransmitter, Neurotransmission and Heteroreceptor.
The Receptor study combines topics in areas such as Biophysics and Cell biology.
Kjell Fuxe has researched Dopamine receptor D2 in several fields, including Adenosine A2A receptor and Adenosine.
He most often published in these fields:
- Internal medicine (55.16%)
- Endocrinology (54.72%)
- Dopamine (29.88%)
What were the highlights of his more recent work (between 2007-2021)?
- Neuroscience (26.58%)
- Receptor (26.15%)
- Internal medicine (55.16%)
In recent papers he was focusing on the following fields of study:
Kjell Fuxe mostly deals with Neuroscience, Receptor, Internal medicine, Endocrinology and Heteroreceptor.
His study looks at the relationship between Neuroscience and fields such as Glutamate receptor, as well as how they intersect with chemical problems.
His Receptor study incorporates themes from Adenosine and Pharmacology.
He interconnects Raphe and Proximity ligation assay in the investigation of issues within Heteroreceptor.
His G protein-coupled receptor research includes elements of Biophysics and Allosteric regulation.
His Dopamine receptor D2 research is under the purview of Dopamine.
Between 2007 and 2021, his most popular works were:
- Evidence for dopamine receptor stimulation by apomorphine (870 citations)
- Functional Role of the Nigro‐Neostriatal Dopamine Neurons*) (363 citations)
- Effect of ergot drugs on central catecholamine neurons: evidence for a stimulation of central dopamine neurons. (352 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Dopamine
Kjell Fuxe spends much of his time researching Neuroscience, Receptor, Dopamine, G protein-coupled receptor and Pharmacology.
His Neuroscience research includes themes of Glutamate receptor, Metabotropic glutamate receptor 5, Neurotransmission and Heteroreceptor.
His study looks at the intersection of Receptor and topics like Drug development with Drug discovery.
Endocrinology and Internal medicine are the focus of his Dopamine studies.
His research investigates the link between Endocrinology and topics such as Receptor antagonist that cross with problems in Competitive antagonist.
His research integrates issues of Agonist, Dopamine receptor D1, Psychiatry and Monoamine neurotransmitter in his study of Pharmacology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
